Subscribe
Close
  • Free for qualified executives and consultants to industry

  • Receive quarterly issues of Area Development Magazine and special market report and directory issues

Renew

Eli Lilly and Company Expands Lebanon, Indiana, Operations

10/09/2024
American pharmaceutical company Eli Lilly and Company plans to expand its operations in Lebanon, Indiana. The $4.5 billion project is expected to create 400 jobs.

The new facility, The Lilly Medicine Foundry, wil be located in the LEAP Research and Innovation District and be a center for advanced manufacturing and drug development. Operations are scheduled to begin in late 2027.

"As we accelerate our work to discover new medicines for the toughest diseases, we're continuing to invest in state-of-the-art infrastructure to support our growing pipeline," said David A. Ricks, Lilly's chair and CEO. "In addition to supplying high-quality medicine for our clinical studies, this new complex will further strengthen our process development and scale up our manufacturing capabilities to speed delivery of next-generation medicines to patients around the world."

The State of Indiana will support the new site with infrastructure improvements for roads, water, electricity and other utilities. The state will also offer economic incentives tied to Lilly's investment and employment goals in Lebanon.

"Lilly's increased investment in Indiana is creating tremendous new career opportunities for Hoosiers," noted Indiana Secretary of Commerce David Rosenberg. "The LEAP district in Lebanon is quickly becoming an international destination, with $18 billion in committed capital investment on 2,300 acres since its launch in 2022. LEAP and the Hardtech Corridor are attracting global leaders, talent and innovation to Indiana."

Exclusive Research